Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
8 Cards in this Set
- Front
- Back
|
Classification of AHF |
|
|
|
Escape Trial |
Routine use of PA catheter in acute HF didnt reduce hospitalization but inc adverse events. CI <2ml/min/m2 ~ cardiogenic shock PCWP > 16 ~ PUL edema |
|
|
3CPO trial |
NIV (CPAP +Bipap) vs med Rx no difference in mortality but dec symptoms & respiratory dep . |
|
|
Dose of thiazide diuertics |
Metolazone 2.5 to 10mg HCTZ 25-50mg Bid CTZ 250-500mg IV 500-1000mg ORAL spironolactone 25-50mg Acetazolamide o.5mg |
|
|
Vasodilators in acute heart failure |
Vasodilator, venodilators, dec filling pressures, inc CO, dec preload and afterload. Nitroglycrine for epicardial coronaries Nitroprudside for intramyocardial vasculature. Coronary steal phenomenon. MAP>65mmHG SBP 90-100mmHG |
|
|
Inodilators= inotropes with vasodilatory properties Levosimendan 0.5-2Microg/kg/min Milrinone o.125-o.75microg/kg/min |
|
|
|
Vasopressors |
Norepinephrine o.2-1microg/kg/min Phenyephrine Dopamine high dose |
|
|
Novel therapies for HF |
Vasodilators Serolaxin Urodilatin Ultratide Neurohormones Endothelin receptor antagonist Aliskerin Gyuanylate cyclase activator Veriguacit Cinaguacit Myosin activators Omecamdive mecarbil |
